1. Home
  2. EDTK vs AFMD Comparison

EDTK vs AFMD Comparison

Compare EDTK & AFMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EDTK
  • AFMD
  • Stock Information
  • Founded
  • EDTK 2013
  • AFMD 2000
  • Country
  • EDTK China
  • AFMD Germany
  • Employees
  • EDTK N/A
  • AFMD N/A
  • Industry
  • EDTK Other Consumer Services
  • AFMD Biotechnology: Pharmaceutical Preparations
  • Sector
  • EDTK Real Estate
  • AFMD Health Care
  • Exchange
  • EDTK Nasdaq
  • AFMD Nasdaq
  • Market Cap
  • EDTK 17.3M
  • AFMD 17.0M
  • IPO Year
  • EDTK 2020
  • AFMD 2014
  • Fundamental
  • Price
  • EDTK $1.00
  • AFMD $0.90
  • Analyst Decision
  • EDTK
  • AFMD Strong Buy
  • Analyst Count
  • EDTK 0
  • AFMD 5
  • Target Price
  • EDTK N/A
  • AFMD $13.50
  • AVG Volume (30 Days)
  • EDTK 13.3K
  • AFMD 78.1K
  • Earning Date
  • EDTK 03-21-2025
  • AFMD 03-27-2025
  • Dividend Yield
  • EDTK N/A
  • AFMD N/A
  • EPS Growth
  • EDTK N/A
  • AFMD N/A
  • EPS
  • EDTK N/A
  • AFMD N/A
  • Revenue
  • EDTK $624,365.00
  • AFMD $6,287,085.00
  • Revenue This Year
  • EDTK N/A
  • AFMD N/A
  • Revenue Next Year
  • EDTK N/A
  • AFMD $225.65
  • P/E Ratio
  • EDTK N/A
  • AFMD N/A
  • Revenue Growth
  • EDTK N/A
  • AFMD N/A
  • 52 Week Low
  • EDTK $0.84
  • AFMD $0.85
  • 52 Week High
  • EDTK $1.27
  • AFMD $8.95
  • Technical
  • Relative Strength Index (RSI)
  • EDTK 47.09
  • AFMD 32.41
  • Support Level
  • EDTK $0.97
  • AFMD $0.95
  • Resistance Level
  • EDTK $1.03
  • AFMD $1.03
  • Average True Range (ATR)
  • EDTK 0.03
  • AFMD 0.06
  • MACD
  • EDTK -0.00
  • AFMD 0.00
  • Stochastic Oscillator
  • EDTK 50.00
  • AFMD 27.14

About EDTK Skillful Craftsman Education Technology Limited

Skillful Craftsman Education Technology Ltd provides online education and technology services in China. The services comprises of two aspects - Online vocational training and Virtual simulation experimental training. It covers a wide range of subjects, including mechanics, electronics, auto repair and construction. Majority of its revenues are generated from the People's Republic of China.

About AFMD Affimed N.V.

Affimed NV is a clinical-stage biopharmaceutical company. The company is engaged in discovering and developing targeted cancer immunotherapies. Its product candidates are being developed in the field of immuno-oncology, which represents an approach to cancer treatment that seeks to harness the body's immune defenses to fight tumor cells. It is active in the discovery, pre-clinical and clinical development of antibodies based on its core technology. The Company generates revenues from the provision of research and development services to third parties based on both Group and third party owned intellectual property. Geographically, it derives a majority of revenue from the United States and also has a presence in and Germany.

Share on Social Networks: